10 Analysts Have This to Say About Merck & Co
Portfolio Pulse from Benzinga Insights
In the last quarter, 10 analysts have provided ratings for Merck & Co (NYSE:MRK), with 2 being bullish, 6 somewhat bullish, and 2 indifferent. The company has an average 12-month price target of $127.7, an increase of 10.56% from the previous average price target of $115.50.
November 09, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts' ratings for Merck & Co are mostly bullish, with an increased 12-month price target, which could positively impact the stock price.
The majority of the analysts are bullish or somewhat bullish on Merck & Co, indicating a positive sentiment towards the company. The increased 12-month price target suggests that analysts expect the stock price to rise, which could lead to a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100